Neoral Capsule, Liquid Filled
Product Images NDC 0078-0248
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neoral (NDC 0078-0248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Study 302 Enrolled 299 Patients With Severe Active Ra, 99% Of Whom Were Unresponsive Or Intolerant To At Least One Prior Major Ra Drug. Patients Were Randomized To 1 Of 2 Treatment Groups (1) Neoral® And (2) Cyclosporine, Both Of Which Were Started At 2.5 mg/kg/day And Increased After 4 Weeks For Inefficacy In Increments Of 0.5 mg/kg/day To A Maximum Of 5 mg/kg/day And Decreased At Any Time For Toxicity. Treatment Duration Was 24 Weeks. The Mean Cyclosporine Dose At The Last Visit Was 2.91 mg/kg/day (range: 0.72-5.17) For Neoral® And 3.27 mg/kg/day (range: 0.73 5.68) For Cyclosporine. (Neoral 03)
Principal Display Panel Novartis Ndc 0078-0246-15 Neoral® Soft Gelatin Capsules (cyclosporine Capsules, Usp) Modified Warning: Neoral® (cyclosporine Capsules, Usp) Modified Is Not Bioequivalent To Sandimmune® (cyclosporine Capsules, Usp). Do Not Use Interchangeably Without A Physician’s Supervision. Rx Only Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936 30 Soft Gelatin Capsules 25 mg (Neoral 04)
Principal Display Panel Novartis Ndc 0078-0248-15 Neoral® Soft Gelatin Capsules (cyclosporine Capsules, Usp) Modified Warning: Neoral® (cyclosporine Capsules, Usp) Modified Is Not Bioequivalent To Sandimmune® (cyclosporine Capsules, Usp). Do Not Use Interchangeably Without A Physician’s Supervision. Rx Only Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936 30 Soft Gelatin Capsules 100 mg (Neoral 01)
Principal Display Panel – Package Label – 100 mg Oral Solution (Neoral 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.